Matthew Taylor
Stock Analyst at Jefferies
(2.67)
# 1,966
Out of 5,149 analysts
185
Total ratings
60.71%
Success rate
10.81%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Buy | $220 → $190 | $174.21 | +9.06% | 5 | Feb 10, 2026 | |
| PEN Penumbra | Downgrades: Hold | $335 → $374 | $340.16 | +9.95% | 2 | Jan 16, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $95 → $105 | $78.13 | +34.39% | 3 | Dec 11, 2025 | |
| PODD Insulet | Maintains: Neutral | $320 → $355 | $241.84 | +46.79% | 16 | Nov 7, 2025 | |
| EW Edwards Lifesciences | Upgrades: Buy | $80 → $98 | $85.28 | +14.92% | 20 | Oct 29, 2025 | |
| SI Shoulder Innovations | Initiates: Buy | $19 | $13.06 | +45.48% | 1 | Aug 25, 2025 | |
| ABT Abbott Laboratories | Upgrades: Buy | $143 → $145 | $113.61 | +27.63% | 17 | Jul 18, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $13.60 | +10.29% | 7 | Apr 14, 2025 | |
| MDT Medtronic | Maintains: Sell | $75 → $76 | $96.71 | -21.41% | 17 | May 24, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $125 | $0.68 | +18,172.18% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $107 → $121 | $175.36 | -31.00% | 9 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $4.36 | +221.10% | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $45 | $23.74 | +89.55% | 2 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $10 | $6.83 | +46.52% | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $58 → $53 | $10.56 | +401.89% | 2 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $22 → $24 | $12.88 | +86.34% | 2 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $345 | $384.59 | -10.29% | 14 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $115 → $130 | $97.97 | +32.69% | 8 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $15.34 | +30.38% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $85 | $43.41 | +95.81% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $91.70 | -18.21% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $245 | $258.28 | -5.14% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $62 | $19.03 | +225.80% | 8 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $122.19 | +71.86% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $13.02 | -7.83% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $73.08 | +71.05% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $73.85 | -32.30% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $497.42 | -57.78% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $96 | $68.43 | +40.29% | 3 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $7 | $3.68 | +90.22% | 1 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $16 | $11.04 | +44.93% | 2 | Jul 19, 2017 |
Becton, Dickinson and Company
Feb 10, 2026
Maintains: Buy
Price Target: $220 → $190
Current: $174.21
Upside: +9.06%
Penumbra
Jan 16, 2026
Downgrades: Hold
Price Target: $335 → $374
Current: $340.16
Upside: +9.95%
GE HealthCare Technologies
Dec 11, 2025
Maintains: Buy
Price Target: $95 → $105
Current: $78.13
Upside: +34.39%
Insulet
Nov 7, 2025
Maintains: Neutral
Price Target: $320 → $355
Current: $241.84
Upside: +46.79%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Buy
Price Target: $80 → $98
Current: $85.28
Upside: +14.92%
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $19
Current: $13.06
Upside: +45.48%
Abbott Laboratories
Jul 18, 2025
Upgrades: Buy
Price Target: $143 → $145
Current: $113.61
Upside: +27.63%
InMode
Apr 14, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $13.60
Upside: +10.29%
Medtronic
May 24, 2024
Maintains: Sell
Price Target: $75 → $76
Current: $96.71
Upside: -21.41%
Allurion Technologies
Feb 9, 2024
Initiates: Buy
Price Target: $125
Current: $0.68
Upside: +18,172.18%
Jan 30, 2024
Downgrades: Hold
Price Target: $107 → $121
Current: $175.36
Upside: -31.00%
Jan 19, 2024
Initiates: Buy
Price Target: $14
Current: $4.36
Upside: +221.10%
Oct 2, 2023
Maintains: Buy
Price Target: $47 → $45
Current: $23.74
Upside: +89.55%
Jul 19, 2023
Initiates: Underperform
Price Target: $10
Current: $6.83
Upside: +46.52%
Jul 12, 2023
Upgrades: Buy
Price Target: $58 → $53
Current: $10.56
Upside: +401.89%
May 24, 2023
Maintains: Hold
Price Target: $22 → $24
Current: $12.88
Upside: +86.34%
May 2, 2023
Maintains: Buy
Price Target: $320 → $345
Current: $384.59
Upside: -10.29%
Mar 31, 2023
Upgrades: Hold
Price Target: $115 → $130
Current: $97.97
Upside: +32.69%
Oct 12, 2022
Initiates: Buy
Price Target: $20
Current: $15.34
Upside: +30.38%
Oct 12, 2022
Initiates: Hold
Price Target: $85
Current: $43.41
Upside: +95.81%
Oct 12, 2022
Initiates: Buy
Price Target: $75
Current: $91.70
Upside: -18.21%
Oct 12, 2022
Initiates: Hold
Price Target: $245
Current: $258.28
Upside: -5.14%
Oct 12, 2022
Initiates: Hold
Price Target: $62
Current: $19.03
Upside: +225.80%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $122.19
Upside: +71.86%
Oct 12, 2022
Initiates: Buy
Price Target: $12
Current: $13.02
Upside: -7.83%
Oct 12, 2022
Initiates: Buy
Price Target: $125
Current: $73.08
Upside: +71.05%
Oct 12, 2022
Initiates: Buy
Price Target: $50
Current: $73.85
Upside: -32.30%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $497.42
Upside: -57.78%
Feb 24, 2022
Upgrades: Buy
Price Target: $96
Current: $68.43
Upside: +40.29%
Dec 17, 2021
Initiates: Neutral
Price Target: $7
Current: $3.68
Upside: +90.22%
Jul 19, 2017
Maintains: Equal-Weight
Price Target: $17 → $16
Current: $11.04
Upside: +44.93%